Skip to main content
Caplight Logo









PeriPear

PeriPear

Private
OxfordHealthcare & Life Scienceshttps://peri-pear.com

Last Round

Pre Seed

Sep 1, 2026

Total Funding Raised

$1.81M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

PeriPear operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Pre Seed round in September 2026.

PeriPear is a healthtech company that develops a wearable device designed to provide automated perineal thermotherapy during childbirth to reduce the risk of perineal tearing.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PeriPear Comparables

Compare PeriPear with similar companies based on industry and business-model similarity.

PeriPear comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ciconia Medical
80%
Materna Medical
78%
Baymatob
66%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PeriPear Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 1, 2026
GrantAug 9, 2026
GrantJun 18, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Nina van Schaick

COO and Co-Founder

Founding Team

Eviatar Natan

Chief Executive Officer and Co Founder

Founding Team

For institutional investors. Book with your work email.

PeriPear Investors

Notable investors and investment history

PeriPear investors
InvestorRounds
ZincPre Seed
FemTech LabPre Seed
Lavender VenturesPre Seed
Sie VenturesPre Seed
Innovate UKGrant, Pre Seed
HERmesaPre Seed
AtVenture PlatformPre Seed
Book a demo to see all 8 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    $1.6M round led by HERmesa

  • Aug 9, 2026

    $100K grant received from Innovate UK.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • is_developingSep 16, 2026

    Peripear Ltd is developing an adhesive, wearable device that automates controlled heat and moisture delivery to the perineum during labour to reduce childbirth injury, with its next phase of clinical, regulatory and product development including First-in-Human testing in partnership with NUHS Singapore in 2027.

  • receives_financingAug 9, 2026

    Peripear Ltd receives $101K through an Innovate UK Women in Innovation Award and grant funding in United Kingdom in Aug '26 to develop a wearable device designed to prevent perineal trauma during labour ahead of its planned first-in-human study.

  • receives_awardAug 9, 2026

    On Aug 9th '26 in United Kingdom, Peripear Ltd receives an Innovate UK Women in Innovation Award and a £74,974 grant from Innovate UK to develop a wearable device designed to prevent perineal trauma during labour.

  • is_developingAug 9, 2026

    On Aug 9th '26 in the United Kingdom, Peripear Ltd is developing a wearable device designed to prevent perineal trauma during labour, supported by an Innovate UK Women in Innovation Award and a £74,974 grant ahead of its planned first-in-human study.

  • is_developingAug 9, 2026

    In the United Kingdom, Peripear Ltd is developing what it describes as the world's first automated perineal thermotherapy wearable to prevent perineal trauma during childbirth, supported by a £74,974 Innovate UK Women in Innovation Award grant ahead of a planned first-in-human study, as reported on Aug 9th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

PeriPear Filings

Explore SEC and related filing metadata, where available.

PeriPear filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PeriPear's valuation, stock price, and market status.

Is PeriPear a public or private company?

PeriPear is a private company.

What is the current stock price of PeriPear?

PeriPear is a private company, so its shares have no public market price. Caplight tracks PeriPear's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PeriPear worth (valuation)?

Valuation information for PeriPear is not publicly available.

Can I buy PeriPear stock?

PeriPear shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PeriPear's last funding round?

PeriPear's most recent funding round was Pre Seed on September 1, 2026.

Who are the main investors in PeriPear?

Key investors in PeriPear include HERmesa.

Will PeriPear IPO soon?

No public IPO plans have been announced for PeriPear.

How can I track PeriPear secondary market activity?

Caplight tracks bids, offers, and trades in PeriPear's shares on secondary markets.

Firmographic Details

HeadquartersOxford
Employee Range9
Year Founded2024
Last FundingSep 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?